Weidong Fei

2.7k total citations · 2 hit papers
61 papers, 2.0k citations indexed

About

Weidong Fei is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Weidong Fei has authored 61 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Biomaterials and 15 papers in Biomedical Engineering. Recurrent topics in Weidong Fei's work include Nanoparticle-Based Drug Delivery (14 papers), Nanoplatforms for cancer theranostics (13 papers) and Reproductive System and Pregnancy (9 papers). Weidong Fei is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), Nanoplatforms for cancer theranostics (13 papers) and Reproductive System and Pregnancy (9 papers). Weidong Fei collaborates with scholars based in China, Australia and Czechia. Weidong Fei's co-authors include Caihong Zheng, Mengdan Zhao, Yao Yao, Yiqing Ye, Xiaoyu Cai, Hongxia Tang, Yunchun Zhao, Caihong Zheng, Chaoqun Li and Qianqian Song and has published in prestigious journals such as Advanced Materials, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Weidong Fei

59 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of short-chain fatty acids in immunity, inflammation and metabolism

2020 511 citations Yao Yao, Xiaoyu Cai et al. profile →
Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer

2022 138 citations Junfen Xu, Yifeng Fang et al. Clinical Cancer Research profile →

Peers

Weidong Fei

BIOMA

PRM

Rui Sun China

Haohuan Li China

Daozhen Chen China

Chih‐Wen Shu Taiwan

Raheleh Halabian Iran

Ziyu Wang China

Ying Yang China

Fatemeh Moheimani Australia

Kamran Mansouri Iran

Rui Sun China

Weidong Fei

825 ×0.8

489 ×1.1

499 ×1.5

BIOMA

195 ×0.7

PRM

202 ×0.7

Citations per year, relative to Weidong Fei Weidong Fei (= 1×) peers Rui Sun

Countries citing papers authored by Weidong Fei

Since Specialization

Citations

This map shows the geographic impact of Weidong Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Fei more than expected).

Fields of papers citing papers by Weidong Fei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Fei. The network helps show where Weidong Fei may publish in the future.

Co-authorship network of co-authors of Weidong Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Fei. A scholar is included among the top collaborators of Weidong Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Fei. Weidong Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Xiaoyu, et al.. (2025). Short‐chain fatty acids regulate T cell heterogeneity to alleviate recurrent spontaneous abortion. British Journal of Pharmacology. 182(23). 5762–5789. 1 indexed citations

Liu, Yunxi, Jialei Zhu, Zhengyun Chen, et al.. (2025). Extracellular matrix dysregulation in PCOS: pathogenesis, therapeutic strategies, and innovative technologies. Journal of Biological Engineering. 19(1). 61–61. 3 indexed citations

Fei, Weidong, Yu Xin, Yunxi Liu, et al.. (2025). Clinical insight-driven micron-sized cholesterol oxidation platform for membrane lipid therapy of advanced ovarian cancer. Journal of Nanobiotechnology. 23(1). 614–614. 1 indexed citations

Wang, Rong, Yunxi Liu, Mingqi Liu, et al.. (2024). Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategies. International Journal of Pharmaceutics. 669. 125028–125028. 2 indexed citations

Xu, Shanshan, et al.. (2024). FXN targeting induces cell death in ovarian cancer stem-like cells through PRDX3-Mediated oxidative stress. iScience. 27(8). 110506–110506. 7 indexed citations

Wu, Huifeng, Xiaodong Wu, Mengdan Zhao, et al.. (2024). Regulating Cholesterol in Tumorigenesis: A Novel Paradigm for Tumor Nanotherapeutics. International Journal of Nanomedicine. Volume 19. 1055–1076. 14 indexed citations

Yan, Jingjing, Xin Yu, Xiaoling Zheng, et al.. (2024). Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis. Journal of Materials Chemistry B. 13(3). 742–762. 4 indexed citations

Xin, Yu, Weidong Fei, Meng Zhang, et al.. (2024). Uterine first-pass effect: Unlocking the potential of vaginally administered ritodrine-loaded thermosensitive gel for uterine drug delivery. European Journal of Pharmaceutical Sciences. 204. 106945–106945. 2 indexed citations

Huang, Yu, Meng Zhang, Yidan Ma, et al.. (2023). Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies. International Journal of Pharmaceutics. 636. 122827–122827. 8 indexed citations

10.

Yao, Yao, Xiaoyu Cai, Meng Zhang, et al.. (2023). Circ-Plod2 destabilizes Mpo mRNA by binding to IGF2BP2 to promote osteogenic differentiation of bone marrow mesenchymal stem cells. European Journal of Pharmacology. 961. 176192–176192. 7 indexed citations

11.

Yang, Shan, Weidong Fei, Yunchun Zhao, et al.. (2023). Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms. International Journal of Nanomedicine. Volume 18. 3035–3046. 9 indexed citations

12.

Xu, Junfen, Yifeng Fang, Kelie Chen, et al.. (2022). Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 28(16). 3590–3602. 138 indexed citations breakdown →

13.

Tang, Miao, Dongli Sun, Yao Yao, et al.. (2022). Size-dependent placental retention effect of liposomes in ICR pregnant mice: Potential superiority in placenta-derived disease therapy. International Journal of Pharmaceutics. 625. 122121–122121. 3 indexed citations

14.

Zhao, Mengdan, Meng Zhang, Weidong Fei, et al.. (2022). Hyaluronic Acid-Modified Nanoplatforms as a Vector for Targeted Delivery of Autophagy-Related Gene to the Endometriotic Lesions in Mice. Frontiers in Bioengineering and Biotechnology. 10. 918368–918368. 15 indexed citations

15.

Fei, Weidong, Meng Zhang, Xiaoyu Fan, et al.. (2021). Engineering of bioactive metal sulfide nanomaterials for cancer therapy. Journal of Nanobiotechnology. 19(1). 93–93. 40 indexed citations

16.

Liu, Yunxi, Yue Chen, Weidong Fei, et al.. (2021). Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic. Frontiers in Bioengineering and Biotechnology. 9. 733792–733792. 3 indexed citations

17.

Zhao, Yunchun, Xiaoling Zheng, Yongquan Zheng, et al.. (2021). Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer. Frontiers in Oncology. 11. 650453–650453. 50 indexed citations

18.

Yao, Yao, Xiaoyu Cai, Weidong Fei, et al.. (2020). Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation. Frontiers in Pharmacology. 11. 594042–594042. 12 indexed citations

19.

Fei, Weidong, Chaoqun Li, Xinjun Cai, et al.. (2020). Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review. International Journal of Pharmaceutics. 583. 119385–119385. 19 indexed citations

20.

Fei, Weidong, Yan Zhang, Shunping Han, et al.. (2017). RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma. International Journal of Pharmaceutics. 519(1-2). 250–262. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact